1. Home
  2. WST vs AEE Comparison

WST vs AEE Comparison

Compare WST & AEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • AEE
  • Stock Information
  • Founded
  • WST 1923
  • AEE 1901
  • Country
  • WST United States
  • AEE United States
  • Employees
  • WST N/A
  • AEE N/A
  • Industry
  • WST Medical/Dental Instruments
  • AEE Power Generation
  • Sector
  • WST Health Care
  • AEE Utilities
  • Exchange
  • WST Nasdaq
  • AEE Nasdaq
  • Market Cap
  • WST 18.9B
  • AEE 27.3B
  • IPO Year
  • WST N/A
  • AEE N/A
  • Fundamental
  • Price
  • WST $253.59
  • AEE $100.79
  • Analyst Decision
  • WST Buy
  • AEE Buy
  • Analyst Count
  • WST 7
  • AEE 11
  • Target Price
  • WST $332.50
  • AEE $102.82
  • AVG Volume (30 Days)
  • WST 575.5K
  • AEE 1.4M
  • Earning Date
  • WST 10-23-2025
  • AEE 11-05-2025
  • Dividend Yield
  • WST 0.35%
  • AEE 2.82%
  • EPS Growth
  • WST N/A
  • AEE 2.91
  • EPS
  • WST 6.68
  • AEE 4.55
  • Revenue
  • WST $2,960,200,000.00
  • AEE $8,119,000,000.00
  • Revenue This Year
  • WST $6.28
  • AEE $15.13
  • Revenue Next Year
  • WST $6.02
  • AEE $6.13
  • P/E Ratio
  • WST $37.92
  • AEE $22.17
  • Revenue Growth
  • WST 2.90
  • AEE 17.75
  • 52 Week Low
  • WST $187.43
  • AEE $82.95
  • 52 Week High
  • WST $352.33
  • AEE $104.10
  • Technical
  • Relative Strength Index (RSI)
  • WST 56.31
  • AEE 53.29
  • Support Level
  • WST $249.94
  • AEE $98.72
  • Resistance Level
  • WST $264.06
  • AEE $101.17
  • Average True Range (ATR)
  • WST 5.67
  • AEE 1.05
  • MACD
  • WST 0.67
  • AEE -0.11
  • Stochastic Oscillator
  • WST 53.28
  • AEE 66.56

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About AEE Ameren Corporation

Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas through the company's two main subsidiaries, Ameren Missouri and Ameren Illinois. It serves 2.5 million electricity customers and approximately 1 million natural gas customers accross its two service territories.

Share on Social Networks: